A LinkedIn post from Pear VC highlights a new episode of its Pear Healthcare Playbook podcast focused on AI-driven patient access. The episode features Assort Health Co-founder and Co-CEO Jeffery L. in conversation with Pear’s Anson Zhou and Andrew Parambath, M.D., M.B.A., exploring how AI voice agents may change how patients connect with healthcare providers.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, the discussion covers Assort Health’s early development, the challenges of securing initial live deployments, and the importance of specialty-specific AI in clinical workflows. The episode also touches on a long-term vision for AI-powered patient access, suggesting Pear VC continues to focus on healthcare AI infrastructure, which could position its portfolio to benefit from efficiency gains and cost reductions in patient intake and communication.
For investors, this emphasis on AI voice agents indicates Pear VC’s interest in automation technologies that target administrative bottlenecks in healthcare. If companies like Assort Health can demonstrate scalable deployments and regulatory alignment, Pear’s exposure to this segment could support value creation through increased adoption by clinics and specialty providers seeking to improve access while managing staffing constraints.